However, the tumor-initiation ability of α2δ1+ cells is the highest among these population (Fig. 3F, Supplementary Table 5), indicating that α2δ1 is the most robust marker for enriching NSCLC TICs compared with CD133 and CD166. Here, ALCAM is linked to non-small cell lung carcinoma.